VENETOCLAX and PYREXIA

Overview

PYREXIA is the #6 most commonly reported adverse reaction for VENETOCLAX, manufactured by AbbVie Inc.. There are 2,566 FDA adverse event reports linking VENETOCLAX to PYREXIA. This represents approximately 2.6% of all 98,823 adverse event reports for this drug.

VENETOCLAX has an overall safety score of 88 out of 100. Patients taking VENETOCLAX who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for VENETOCLAX, but still significant enough to appear in the safety profile.

Other Side Effects of VENETOCLAX

In addition to pyrexia, the following adverse reactions have been reported for VENETOCLAX:

• DEATH — 9,739 reports
• OFF LABEL USE — 6,503 reports
• NEUTROPENIA — 3,217 reports
• FEBRILE NEUTROPENIA — 2,966 reports
• PLATELET COUNT DECREASED — 2,621 reports
• PNEUMONIA — 2,542 reports
• FATIGUE — 2,479 reports
• DIARRHOEA — 2,261 reports
• MYELOSUPPRESSION — 2,143 reports
• WHITE BLOOD CELL COUNT DECREASED — 2,103 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does VENETOCLAX cause PYREXIA?

PYREXIA has been reported as an adverse event in 2,566 FDA reports for VENETOCLAX. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with VENETOCLAX?

PYREXIA accounts for approximately 2.6% of all adverse event reports for VENETOCLAX, making it a notable side effect.

What should I do if I experience PYREXIA while taking VENETOCLAX?

If you experience pyrexia while taking VENETOCLAX, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages